Genetic polymorphisms in Spanish rheumatoid arthritis patients: An association and linkage study

Genes and Immunity

Volumn 4, Issue 2, 2003, Pages 117-121

  Martinez, Alf ^a   Pascual, M ^b   Pascual Salcedo, D ^c   Balsa, A ^c   Martin, J ^b   de la Concha, E G ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Immunogenetics; Microsatellite; Rheumatoid arthritis; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; MICROSATELLITE DNA;

ARTICLE; CONTROLLED STUDY; ETHNOLOGY; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; LINKAGE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; VARIABLE NUMBER OF TANDEM REPEAT; CASE CONTROL STUDY; GENETICS;

ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); MINISATELLITE REPEATS; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN;

EID: 0642309019     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363931     Document Type: Article

References (27)

1. Martinez A, Fernandez-Arquero M, Balsa A et al. Primary association of a MICA allele with protection against rheumatoid arthritis. Arthritis Rheum 2001; 44: 1261-1265.
2. Martinez A, Fernandez-Arquero M, Pascual-Salcedo D et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 2000; 43: 1366-1370.
3. Pascual M, Nieto A, Mataran L, Balsa A, Pascual-Salcedo D, Martin J. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000; 1: 338-340.
4. Nieto A, Caliz R, Pascual M, Mataran L, Garcia S, Martin J. Involvement of Fcgamma receptor IIIA genotypes in susceptibility to rheumatoid arthritis. Arthritis Rheum 2000; 43: 735-739.
5. Fishman D, Faulds G, Jeffery R et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369-1376.
6. Eskdale J, Gallagher G. A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics 1995; 42: 444-445.
7. Eskdale J, Kube D, Gallagher G. A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene. Immunogenetics 1996; 45: 82-83.
8. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics 1997; 46: 120-128.
9. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
10. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465-9470.
11. Cantagrel A, Navaux F, Loubet-Lescoulie P et al. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 1999; 42: 1093-1100.
12. Hajeer AH, Lazarus M, Turner D et al. IL-10 gene promoter polymorphisms in rheumatoid arthritis. Scand J Rheumatol 1998; 27: 142-145.
13. Eskdale J, McNicholl J, Wordsworth P et al. Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet 1998; 352: 1282-1283.
14. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998; 16: 27-55.
15. Tarlow JK, Blakemore AI, Lennard A et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91: 403-404.
16. Allcock RJ, Christiansen FT, Price P. The central MHC gene IKBL carries a structural polymorphism that is associated with HLA-A3,B7,DR15. Immunogenetics 1999; 49: 660-665.
17. de la Concha EG, Fernandez-Arquero M, Lopez-Nava G et al. Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 2000; 119: 1491-1495.
18. Salmon JE, Pricop L. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. Arthritis Rheum 2001; 44: 739-750.
19. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001; 19: 275-290.
20. Morgan AW, Griffiths B, Ponchel F et al. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 2000; 43: 2328-2334.
21. Nieto A, Pascual M, Caliz R, Mataran L, Martin J. Association of Fc? receptor IIIA polymorphism with rheumatoid arthritis: comment on the article by Morgan et al. Arthritis Rheum 2002; 46: 556-557.
22. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166: 3915-3922.
23. Kube D, Rieth H, Eskdale J, Kremsner PG, Gallagher G. Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene. Genes Immun 2001; 2: 181-190.
24. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun 2000; 1: 231-233.
25. Mullighan CG, Marshall SE, Bunce M, Welsh KI. Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency. Genes Immun 1999; 1: 137-148.
26. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus- host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941-3946.
27. Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti- inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637-642.